This negative modulation of ENT1 and dCK gene expression aligns with findings in the cytarabine-resistant HL-60 human leukemic cell line and in chemoresistant acute myeloid leukemia samples [31,36]. Here, SLC29A1 is linked to acute myeloid leukemia.